Viewing Study NCT03575351


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-03-17 @ 12:03 PM
Study NCT ID: NCT03575351
Status: COMPLETED
Last Update Posted: 2025-08-03
First Post: 2018-06-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Hodgkin Lymphomas View
None DLBCL View
None Efficacy View
None Safety View
None JCAR017 View
None Liso-cel View
None High-Risk View
None Relapsed View
None Refractory View
None B-cell NHL View